Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT04260243

Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease

The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

COPD Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

So far, there are no previous studies that analyze the effects of a myofascial relaxation protocol applied to the diaphragm within the respiratory rehabilitation treatment in patients with chronic obstructive pulmonary disease.

Aim: The main objective of this study is to assess the effects of a 3 weeks myofascial release protocol applied to the diaphragm on respiratory parameters in patients with chronic obstructive pulmonary disease.

Design: Randomized clinical trial

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COPD;
  • Forced expiratory volume in the first second (FEV1) < 80%;
  • FEV1/Forced vital capacity (FVC) < 70%;
  • Maximal inspiratory pressure (MIP) < 70%.

Exclusion criteria

  • Recent (6 months) spine or abdominal surgery;
  • Allergic status of any kind;
  • systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);
  • neuromuscular or neurological injuries;
  • previous myofascial release treatment.

Treatment and study plan

Experimental-Myofascial + Respiratory rehabilitation

Other

6 sessions of: Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)

Sham Myofascial + Respiratory rehabilitation

Other

6 sessions of: Sham Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)

Primary outcomes

  1. Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score

    Time frame: 3 weeks

    Score (0-40) higher scores mean a worse outcome.

Secondary outcomes

  1. 6 Minutes Walking Test

    Time frame: 3 weeks

    Maximum distance reached

Study contacts

Contact information is provided by the study sponsor or research team.

JUAN FRANCISCO L PÁRRAGA, PhD

CONTACT

[email protected]

618055092

MARÍA DOLORES ARGUISUELAS, PhD

CONTACT

[email protected]

961369000 ext. 64352

Sponsors and collaborators

Lead sponsor

Cardenal Herrera University

Other

Registry information

Official study title

Effects of Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease: a Randomized Clinical Trial

Acronym: MFR-COPD

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 7, 2020
Registry last updated
Feb 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.